Stocks and Investing
Stocks and Investing
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $40 on, Jan 30th, 2023
Edward Nash of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $33 to $40 on, Jan 30th, 2023.
Edward has made no other calls on TVTX in the last 4 months.
There are 4 other peers that have a rating on TVTX. Out of the 4 peers that are also analyzing TVTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022
These are the ratings of the 3 analyists that currently disagree with Edward
- Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $42 on, Wednesday, January 11th, 2023
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $38 on, Thursday, October 20th, 2022
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $36 on, Monday, October 17th, 2022
Contributing Sources